Immunomodulatory effects of a plasmid expressing B7‐2 on human immunodeficiency virus‐1‐specific cell‐mediated immunity induced by a plasmid encoding the viral antigen

No abstract is available for this paper.

• Publication year

  1997

• Venue

  European Journal of Immunology

• Publication date

  1997-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/eji.1830270329PMID 9079822
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HIV‐1‐specific cell‐mediated immunity is enhanced by co‐inoculation of TCA3 expression plasmid with DNA vaccine

  1997cited by this paper
• Irradiated B7-1 transduced primary acute myelogenous leukemia (AML) cells can be used as therapeutic vaccines in murine AML.

  1996cited by this paper
• Tumor rejection requires a CTLA4 ligand provided by the host or expressed on the tumor: superiority of B7-1 over B7-2 for active tumor immunization.

  1996cited by this paper
• B7-1 but not B7-2 efficiently costimulates CD8+ T lymphocytes in the P815 tumor system in vitro.

  1996cited by this paper
• Costimulatory protein B7-1 enhances the cytotoxic T cell response and antibody response to hepatitis B surface antigen.

  1996cited by this paper
• HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

  1995cited by this paper
• CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription.

  1995cited by this paper
• Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines.

  1995cited by this paper
• A B7‐1‐transfected human melanoma line stimulates proliferation and cytotoxicity of autologous and allogeneic lymphocytes

  1995cited by this paper
• Neutralization of HIV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate

  1995cited by this paper
• Errata

  1995cited by this paper
• Induction of Potent Humoral and Cell-Mediated Immune Responses Following Direct Injection of DNA Encoding the HIV Type 1 env and rev Gene Products

  1995cited by this paper
• Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules.

  1995cited by this paper
• New perspectives of C1328-137-mediated T cell costimulation

  1995cited by this paper
• CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL.

  1995cited by this paper
• Immune responses to nucleic acid vaccines to rabies virus.

  1995cited by this paper
• B7 costimulation is necessary for the activation of the lytic function in cytotoxic T lymphocyte precursors.

  1995cited by this paper
• Exposing the immunology of naked DNA vaccines.

  1995cited by this paper
• New perspectives of CD28-B7-mediated T cell costimulation.

  1995cited by this paper
• Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function

  1994cited by this paper
• Cloned human CD8+ cytotoxic T lymphocytes protect human peripheral blood leukocyte-severe combined immunodeficient mice from HIV-1 infection by an HLA-unrestricted mechanism.

  1994cited by this paper
• The B7 and CD28 receptor families.

  1994cited by this paper
• The immunobiology of muscle.

  1994cited by this paper
• Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients.

  1994cited by this paper
• Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.

  1994cited by this paper
• Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production

  1993cited by this paper
• Quantitative analysis of the human immunodeficiency virus type 1 (HIV- 1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein- Barr virus in late disease

  1993cited by this paper
• Gene inoculation generates immune responses against human immunodeficiency virus type 1.

  1993cited by this paper
• Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells.

  1993cited by this paper
• Strong immunogenicity of a multicomponent peptide vaccine developed with the branched lysine oligopeptide method for human immunodeficiency virus infection

  1993cited by this paper
• Heterologous protection against influenza by injection of DNA encoding a viral protein.

  1993cited by this paper
• Naked DNA points way to vaccines.

  1993cited by this paper
• Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule.

  1992cited by this paper
• CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes

  1992cited by this paper
• Inverse relationship of CD8+CD11+ suppressor T cells with human immunodeficiency virus (HIV)-specific cellular cytotoxicity and natural killer cell activity in HIV infection.

  1991cited by this paper
• Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7

  1991cited by this paper
• CTLA-4 is a second receptor for the B cell activation antigen B7

  1991cited by this paper
• Direct gene transfer into mouse muscle in vivo.

  1990cited by this paper
• IL-2 and IFN-gamma are two necessary lymphokines in the development of cytolytic T cells.

  1989cited by this paper
• Interferon‐γ is not an antiviral, but a growth‐promoting factor for t lymphocytes

  1988cited by this paper
• Interferon-gamma is not an antiviral, but a growth-promoting factor for T lymphocytes.

  1988cited by this paper
• Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones.

  1987cited by this paper
• Interferon: a cytotoxic T lymphocyte differentiation signal

  1986cited by this paper
• Genetic control of immune response to sperm whale myoglobin in mice. II. T lymphocyte proliferative response to the synthetic antigenic sites.

  1979cited by this paper

• Genetic adjuvants: A paradigm shift in vaccine development and immune modulation

  2025cites this paper
• Characterization of Co-Stimulatory Ligand CD80/86 and Its Effect as a Molecular Adjuvant on DNA Vaccine Against Vibrio anguillarum in Flounder (Paralichthys olivaceus)

  2022cites this paper
• Development of Gene-Based Vectors for Immunization

  2017cites this paper
• Immunogenicity and efficacy of a plasmid DNA rabies vaccine incorporating Myd88 as a genetic adjuvant

  2014cites this paper
• Co-delivery of LIGHT expression plasmid enhances humoral and cellular immune responses to HIV-1 Nef in mice

  2014cites this paper
• Biomaterials at the interface of nano- and micro-scale vector-cellular interactions in genetic vaccine design.

  2014cites this paper
• Immune Responses to DNA Vaccines: Induction of CD8 T Cells

  2013cites this paper
• and Induces Protective Immunity to Infectious and Humoral and Cellular Immune Responses CD40 Ligand/Trimer DNA Enhances Both

  2013cites this paper
• Synthetic DNA Vaccines: Improved Vaccine Potency by Electroporation and Co-Delivered Genetic Adjuvants

  2013cites this paper
• Improvement of DNA Vaccines by Electroporation

  2012cites this paper
• Fighting with the Enemys Weapons? The Role of Costimulatory Molecules in HIV

  2011cites this paper
• Fighting with the enemy's weapons? the role of costimulatory molecules in HIV.

  2011cites this paper
• Enhanced anti-tumor effect of a gene gun-delivered DNA vaccine encoding the human papillomavirus type 16 oncoproteins genetically fused to the herpes simplex virus glycoprotein D.

  2011cites this paper
• Use of B7 costimulatory molecules as adjuvants in a prime-boost vaccination against Visna/Maedi ovine lentivirus.

  2009cites this paper
• Strategies for enhancing DNA vaccine potency by targeting antigen-presenting cells

  2009cites this paper
• Cytokines as adjuvants for improving anti-HIV responses

  2008cites this paper
• B7 Costimulation Molecules Expressed from the Herpes Simplex Virus 2 Genome Rescue Immune Induction in B7-Deficient Mice

  2007cites this paper
• Nanochemistry-based immunotherapy for HIV-1.

  2007cites this paper
• Immune Responses to a Dicistronic Plasmid Expressing HBsAg of Hepatitis B Virus and Interferon-γ

  2007cites this paper
• Approaches to studying costimulation of human antiviral T cell responses

  2006cites this paper
• Antitumor efficacy of DNA vaccination to the epigenetically acting tumor promoting transcription factor BORIS and CD80 molecular adjuvant

  2006cites this paper
• Toll-Like Receptor Adaptor Molecules Enhance DNA-Raised Adaptive Immune Responses against Influenza and Tumors through Activation of Innate Immunity

  2006cites this paper
• DNA vaccination in immunotherapy of cancer.

  2005cites this paper
• Immunity in response to particulate antigen-delivery systems.

  2005cites this paper
• Feline B7.1 and B7.2 proteins produced from swinepox virus vectors are natively processed and biologically active: potential for use as nonchemical adjuvants.

  2005cites this paper
• Macrophage inflammatory protein‐1α expression plasmid enhances DNA vaccine‐induced immune responses against HSV‐2

  2005cites this paper
• Development of novel vaccines using DNA shuffling and screening strategies.

  2004cites this paper
• The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses

  2004cites this paper
• Human immunodeficiency virus type 2 DNA vaccine provides partial protection from acute baboon infection.

  2004cites this paper
• Codon Optimization of the Tat Antigen of Human Immunodeficiency Virus Type 1 Generates Strong Immune Responses in Mice following Genetic Immunization

  2004cites this paper
• Approaches for the design and evaluation of HIV-1 DNA vaccines

  2004cites this paper
• Enhancement of human immunodeficiency virus type 1‐DNA vaccine potency through incorporation of T‐helper 1 molecular adjuvants

  2004cites this paper
• Immunization with a vaccine that combines the expression of MUC1 and B7 co-stimulatory molecules prolongs the survival of mice and delays the appearance of mouse mammary tumors

  2004cites this paper
• Adjuvant formulations and delivery systems for DNA vaccines.

  2003cites this paper
• A DNA vaccine containing inverted terminal repeats from adeno‐associated virus increases immunity to HIV

  2003cites this paper
• A pattern matching algorithm for codon optimization and CpG motif-engineering in DNA expression vectors

  2003cites this paper
• Codon Optimization for DNA Vaccines and Gene Therapy Using Pattern Matching

  2003cites this paper
• Chitin Micro-Particles (CMP): A Useful Adjuvant for Inducing Viral Specific Immunity when Delivered Intranasally with an HIV-DNA Vaccine

  2003cites this paper
• Costimulatory Molecule Immune Enhancement in a Plasmid Vaccine Model Is Regulated in Part Through the Ig Constant-Like Domain of CD80/86 1

  2003cites this paper
• Novel immunisation strategies against Salmonella

  2003cites this paper
• Cytokines and Immunomodulatory Ligands as Genetic Adjuvants

  2003cites this paper
• CD80 (B7-1) and CD86 (B7-2) are Functionally Equivalent in the Initiation and Maintenance of CD4+ T-Cell Proliferation after Activation with Suboptimal Doses of PHA

  2002cites this paper
• Optimizing the Efficacy of Epitope-Directed DNA Vaccination1

  2002cites this paper
• Enhancement of Antibody Responses to an HIV-2 DNA Envelope Vaccine Using an Expression Vector Containing a Constitutive Transport Element

  2002cites this paper
• Immune responses in baboons vaccinated with HIV‐2 genetic expression libraries

  2002cites this paper
• Systemic and mucosal immune responses in mice after rectal and vaginal immunization with HIV-DNA vaccine.

  2002cites this paper
• Multi-Plasmid Vaccines for HIV-1: Issues and Advancements

  2001cites this paper
• Codelivery of DNA coding for the soluble form of CD86 results in the down-regulation of the immune response to DNA vaccines.

  2001cites this paper
• Genetic adjuvants for DNA vaccines.

  2001cites this paper
• Optimisation of DNA vaccines for the prophylaxis and modulation of herpes simplex virus infections

  2001cites this paper
• Animal Cell Technology: From Target to Market

  2001cites this paper
• Vaccination with glutamic acid decarboxylase plasmid DNA protects mice from spontaneous autoimmune diabetes and B7/CD28 costimulation circumvents that protection.

  2001cites this paper
• Modulation of antigen-specific cellular immune responses to DNA vaccination in rhesus macaques through the use of IL-2, IFN-gamma, or IL-4 gene adjuvants.

  2001cites this paper
• Analysis of the Costimulatory Requirements for Generating Human Virus-Specific in Vitro T Helper and Effector Responses

  2001cites this paper
• HIV DNA Vaccination: Advances and Experiences

  2001cites this paper
• Elevated gastrin secretion by in vivo gene electroporation in skeletal muscle.

  2001cites this paper
• Topical application of HIV DNA vaccine with cytokine-expression plasmids induces strong antigen-specific immune responses.

  2001cites this paper
• Immunologic characterization of HIV-specific DNA vaccine.

  2001cites this paper
• Modulation of the immune response to DNA vaccine by co‐delivery ofcostimulatory molecules

  2000influential citation
• Chemokine Gene Adjuvants Can Modulate Immune Responses Induced by DNA Vaccines

  2000cites this paper
• Sequence analyses of feline B7 costimulatory molecules.

  2000cites this paper
• 4-1BB Costimulation Is Required for Protective Anti-Viral Immunity After Peptide Vaccination1

  2000cites this paper
• The Timing of GM-CSF Expression Plasmid Administration Influences the Th1/Th2 Response Induced by an HIV-1-Specific DNA Vaccine1

  2000cites this paper
• LFA-3 plasmid DNA enhances Ag-specific humoral- and cellular-mediated protective immunity against herpes simplex virus-2 in vivo: involvement of CD4+ T cells in protection.

  2000cites this paper
• DNA vaccines for viral infections: basic studies and applications.

  2000cites this paper
• Genetic Immunization

  2000cites this paper
• Optimization of DNA vaccines through the use of molecular adjuvants.

  2000cites this paper
• Macrophage Colony-Stimulating Factor Can Modulate Immune Responses and Attract Dendritic Cells in Vivo

  2000cites this paper
• Rectal and vaginal immunization with a macromolecular multicomponent peptide vaccine candidate for HIV-1 infection induces HIV-specific protective immune responses.

  2000cites this paper
• Adjuvanted vaccine strategies and live vector approaches for the prevention of AIDS.

  2000cites this paper
• B7 co‐stimulatory requirements differ for induction of immune responses by DNA, protein and recombinant pox virus vaccination

  2000cites this paper
• This information is current as Vaccination PeptideProtective Anti-Viral Immunity After 4-1 BB Costimulation Is Required for Sette

  2000cites this paper
• Cytokine and costimulatory factor-encoding plasmids as adjuvants for DNA vaccination.

  2000cites this paper
• DNA vaccines: immunology, application, and optimization*.

  2000cites this paper
• 8 Br-cAMP enhances both humoral and cell-mediated immune responses induced by an HIV-1 DNA vaccine

  2000cites this paper
• Physiological roles of gammadelta T-cell receptor intraepithelial lymphocytes in cytoproliferation and differentiation of mouse intestinal epithelial cells.

  1999cites this paper
• Macrophage inflammatory protein‐1α (MIP‐1α) expression plasmid enhances DNA vaccine‐induced immune response against HIV‐1

  1999cites this paper
• Genes That Induce Immunity—DNA Vaccines

  1999cites this paper
• DNA immunization with Plasmodium falciparum serine repeat antigen: regulation of humoral immune response by coinoculation of cytokine expression plasmid.

  1999cites this paper
• Immunization of RANTES expression plasmid with a DNA vaccine enhances HIV-1-specific immunity.

  1999cites this paper
• Enhancement of DNA vaccine potency using conventional aluminum adjuvants.

  1999cites this paper
• Intracellular adhesion molecule-1 modulates beta-chemokines and directly costimulates T cells in vivo.

  1999cites this paper
• Modulation of cell surface protein expression by infection with HIV-1

  1999cites this paper
• Review article Roles of Langerhans cells in genetic immunization

  1999cites this paper
• Procédés et produits pour induire une immunité mucosale

  1999cites this paper
• DNA vaccination against the ovarian carcinoma-associated antigen folate receptor alpha (FRalpha) induces cytotoxic T lymphocyte and antibody responses in mice.

  1999cites this paper
• Genetic vaccines.

  1999cites this paper
• In Vivo Modulation of Vaccine-Induced Immune Responses toward a Th1 Phenotype Increases Potency and Vaccine Effectiveness in a Herpes Simplex Virus Type 2 Mouse Model

  1999cites this paper
• Development of multicomponent DNA vaccination strategies against HIV.

  1999cites this paper
• Macrophage inflammatory protein-1alpha (MIP-1alpha) expression plasmid enhances DNA vaccine-induced immune response against HIV-1.

  1999cites this paper
• DNA vaccination against the ovarian carcinoma-associated antigen folate receptor α (FRα) induces cytotoxic T lymphocyte and antibody responses in mice

  1999cites this paper
• Dendritic cells in genetic immunization

  1999cites this paper
• Roles of Langerhans cells in genetic immunization.

  1999cites this paper
• CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo.

  1999cites this paper
• Immunomodulatory effect of a plasmid expressing CD40 ligand on DNA vaccination against human immunodeficiency virus type‐1

  1999cites this paper
• DNA vaccines for viral diseases.

  1999cites this paper
• Chapter 15. DNA Vaccines Coming of Age

  1999cites this paper
• Physiological roles of γδ T‐cell receptor intraepithelial lymphocytes in cytoproliferation and differentiation of mouse intestinal epithelial cells

  1999cites this paper
• Modulation of amplitude and direction of in vivo immune responses by co‐administration of cytokine gene expression cassettes with DNA immunogens

  1998cites this paper
• The search for a potent DNA vaccine against AIDS: the enhancement of immunogenicity by chemical and genetic adjuvants.

  1998cites this paper